Jacobs Levy Equity Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-16,178
Closed -$601K 1069
2019
Q4
$601K Buy
+16,178
New +$576K 0.01% 763
2019
Q1
Sell
-14,939
Closed -$619K 1016
2018
Q4
$619K Buy
+14,939
New +$620K 0.01% 703
2016
Q3
Sell
-94,835
Closed -$3.17M 1095
2016
Q2
$3.17M Sell
94,835
-559,403
-86% -$17.9M 0.07% 340
2016
Q1
$18.4M Sell
654,238
-976,200
-60% -$27.9M 0.39% 68
2015
Q4
$49.9M Buy
1,630,438
+123,550
+8% +$3.89M 0.99% 15
2015
Q3
$44.9M Sell
1,506,888
-104,799
-7% -$3.36M 0.92% 15
2015
Q2
$51.3M Sell
1,611,687
-6,082
-0.4% -$198K 0.98% 13
2015
Q1
$53.4M Sell
1,617,769
-85,110
-5% -$2.71M 0.91% 19
2014
Q4
$50.3M Sell
1,702,879
-285,866
-14% -$8.2M 0.86% 19
2014
Q3
$55.8M Sell
1,988,745
-4,195
-0.2% -$118K 0.93% 12
2014
Q2
$56.1M Buy
1,992,940
+1,754,320
+735% +$50M 0.93% 11
2014
Q1
$7.27M Sell
238,620
-1,149,061
-83% -$34.3M 0.12% 217
2013
Q4
$40.3M Buy
1,387,681
+987,188
+246% +$28.7M 0.61% 32
2013
Q3
$10.9M Sell
400,493
-332,959
-45% -$9.06M 0.18% 160
2013
Q2
$19.5M Buy
+733,452
New +$20.3M 0.34% 78

Other funds holding PFE

Jacobs Levy Equity Management's PFE Position: Q1 2020 in Review

Jacobs Levy Equity Management sold out of Pfizer (PFE) in Q1 2020, closing a stake of 16,178 shares — an estimated $601K sold.

Jacobs Levy Equity Management first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $56.1M in Q2 2014. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Jacobs Levy Equity Management reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 16,178 Pfizer shares in Q1 2020, an estimated $601K.
  • Jacobs Levy Equity Management first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Pfizer position peaked at $56.1M in Q2 2014.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.